Goodman Noah
- SEC CIK
- 0002060075
In the past year, 5 open-market sale filings worth $2.22M and no purchases.
Current role at each company
- KYMR Kymera Therapeutics, Inc.Chief Business Officeras of Jul 2, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $2.22M
- 5 filings
- Net
- −$2.22M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Goodman Noah as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 2, 2026 (view filing)6:30 PM ET | Jul 1 | 1 day | Goodman NoahChief Business Officer | SSale | −3.39K | $114.29 | −$387.3K | −6.7%47.2K after | 10b5-1 |
| Jun 25, 2026 (view filing) | Jun 25 | Same day | Goodman NoahChief Business Officer | SSale | −5.00K | $114.00 | −$570.0K | −9.1%50.2K after | 2 lots10b5-1 |
| Jun 22, 2026 (view filing) | Jun 22 | Same day | Goodman NoahChief Business Officer | SSale | −2.50K | $99.00 | −$247.5K | −4.7%50.2K after | 10b5-1 |
| Apr 16, 2026 (view filing) | Apr 14 | 2 days | Goodman NoahChief Business Officer | SSale | −1.35K | $90.00 | −$121.2K | −2.6%50.2K after | 10b5-1 |
| Apr 10, 2026 (view filing) | Apr 9-10 | 1 day | Goodman NoahChief Business Officer | SSale | −10.3K | $87.47 | −$897.8K | −16.6%51.5K after | 4 lots10b5-1 |